REUTERS - India's stock markets fell on Tuesday, a day after hitting a six-week high, dragged down by drugmaker Lupin
The BOJ held policy steady as expected and said the country's exports and production have been sluggish due mainly to the effects of slowing emerging markets growth, a slightly bleaker view than the one it gave in January.
With the global economy slowing and many countries facing deflationary pressures, investors' focus remain squarely on policy decisions from major central banks.
Up next is the U.S. Federal Reserve, on Wednesday. The Fed is not expected to raise interest rates, but investors will be keenly watching for clues about future hikes and the central bank's view on the economy.
"The market is waiting to see the Fed commentary and if at all there is any decision on the rates. If it becomes too hawkish, then that could have an impact on the market," said Dipen Shah, senior vice-president at Kotak Securities.
Also Read
Data late on Monday showed India's inflation eased more-than-expected in February, which leaves the door open for the central bank to cut repo rates at its meeting on April 5.
"There is a probability that the decision might come some time before the policy. But I think since its an annual policy, the governor may take the opportunity to cut rates and give guidance for the next year," said Shah.
The broader NSE Nifty was down 0.65 percent at 7489.60 at 0637 GMT, while the benchmark BSE Sensex was down 0.63 percent at 24,648.25.
Lupin
Among the gainers were oil retailers such as BPCL
IDBI Bank
(Reporting by Aastha Agnihotri in Bengaluru; Editing by Savio D'Souza)